SRDX | Surmodics, Inc.
Next ER: April 26, 2023 Before Market Opens
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays.
NYSE - New York Stock Exchange
More profiles and info about the company
News for (SRDX)
This company doesn't provide a dividend.
Talk about Surmodics, Inc. below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
( FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Support this project
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.